Cynosure, Inc.  

(Public, NASDAQ:CYNO)   Watch this stock  
Find more results for CYNO
20.96
-0.04 (-0.19%)
Oct 1 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 20.57 - 21.05
52 week 18.63 - 31.48
Open 20.94
Vol / Avg. 122,707.00/153,496.00
Mkt cap 457.35M
P/E 41.06
Div/yield     -
EPS 0.51
Shares 21.64M
Beta 1.46
Inst. own 85%
Oct 28, 2014
Q3 2014 Cynosure Inc Earnings Release - 9:30AM EDT - Add to calendar
Sep 18, 2014
Cynosure Inc at Maxim Group Aesthetics Dinner
Sep 8, 2014
Cynosure Inc. Conference Call to discuss the Acquisition of Assets of RF Medical Device from Ellman International Inc. - Webcast
Aug 13, 2014
Cynosure Inc at Canaccord Genuity Growth Conference - Webcast
Jul 29, 2014
Q2 2014 Cynosure Inc. Earnings Release
Jul 29, 2014
Q2 2014 Cynosure Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 6.30% -0.73%
Operating margin 8.82% -2.58%
EBITD margin - 15.48%
Return on average assets 4.30% -0.51%
Return on average equity 5.43% -0.63%
Employees 576 -
CDP Score - -

Address

5 Carlisle Road
WESTFORD, MA 01886
United States - Map
+1-978-2564200 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Cynosure Inc. (Cynosure) develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair rejuvenate the skin through the treatment of vascular and pigmented lesions, remove multi-colored tattoos, liquefy and remove unwanted fat through laser lypolysis, reduce cellulite and treat onychomycosis. The Company�s systems includes a range of laser and other light-based energy sources, including Alexandrite, pulse dye, Nd:Yag and diode lasers, as well as intense pulsed light. It offers single energy source systems, as well as workstations that include two or more different types of lasers or pulsed light technologies. In September 2014, the Company acquired the assets of Ellman International, Inc.

Officers and directors

Michael R. Davin Chairman of the Board, Chief Executive Officer
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Timothy W. Baker President, Chief Financial Officer, Chief Operating Officer, Treasurer
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Douglas J. Delaney Executive Vice President - Worldwide Sales
Age: 47
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William O. Flannery Director
Age: 68
Bio & Compensation  - Reuters
Brian M. Barefoot Independent Director
Age: 70
Bio & Compensation  - Reuters
Ettore V. Biagioni Independent Director
Age: 55
Bio & Compensation  - Reuters
Marina Hatsopoulos Independent Director
Age: 48
Bio & Compensation  - Reuters
Thomas H. Robinson Independent Director
Age: 55
Bio & Compensation  - Reuters